For research use only. Not for therapeutic Use.
Quilizumab (Anti-Human NGcGM3 Recombinant Antibody) is a humanized IgG1κ monoclonal antibody. Quilizumab targets the M1-prime segment of membrane-expressed IgE, leading to depletion of IgE-switched and memory B cells. Quilizumab has the potantial for the asthma research[1].
| Catalog Number | I042407 |
| CAS Number | 1228538-47-3 |
| Purity | ≥95% |
| Reference | [1]. Jeffrey M Harris, et al. A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma. Respir Res. 2016 Mar 18;17:29. |
